Everself & Harvard Study: ESG Helps Patients Continue Losing Weight After Stopping GLP-1 Medications
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Find in-depth articles and updates on weight loss procedures and GLP-1 medications, made accessible and easy to understand.
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Global leader in endoscopic weight loss, Triple-board-certified in obesity
Harvard Assistant Professor, Chair of American Society for Gastrointestinal Endoscopy's Advanced Endoscopy Committee, Everself Co-founder
Bariendo is now Everself. Learn more